RAPT Therapeutics, Inc.
RAPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $64,403 | $952,703 | $644,300 | $1,006,046 |
| - Cash | $169,735 | $47,478 | $38,946 | $24,027 |
| + Debt | $4,492 | $6,906 | $8,990 | $0 |
| Enterprise Value | -$100,840 | $912,131 | $614,344 | $982,019 |
| Revenue | $0 | $0 | $1,527 | $3,813 |
| % Growth | – | -100% | -60% | – |
| Gross Profit | $0 | $0 | $1,527 | $3,813 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$134,898 | -$125,846 | -$84,748 | -$68,213 |
| % Margin | – | – | -5,550% | -1,789% |
| Net Income | -$129,865 | -$116,798 | -$83,838 | -$69,204 |
| % Margin | – | – | -5,490.4% | -1,814.9% |
| EPS Diluted | -25.488 | -24.372 | -20.611 | -20.213 |
| % Growth | -4.6% | -18.2% | -2% | – |
| Operating Cash Flow | -$83,297 | -$97,048 | -$70,771 | -$61,026 |
| Capital Expenditures | -$122 | -$1,125 | -$845 | -$755 |
| Free Cash Flow | -$83,419 | -$98,173 | -$71,616 | -$61,781 |